Skip to main content

Table 2 Prevalence of multidrug-resistant gram-negative organisms in males tested positive for HIV and males tested negative for HIV

From: Elevated prevalence of multidrug-resistant gram-negative organisms in HIV positive men

  HP HN
Number of patients (n) 109 109
Median age and standard deviation (years) 46; 10.8 46; 11.0
Tested positive for MDRGN
(%; 95% CI; n)
23.9; 16.2–32.9; 26 8.3; 3.8–15.1; 9
Total number of MDRGN isolates (n) 35
Thereof (n) 26 9
E. coli ESBL/FQ (%; 95%CI; n) 73.1; 52.2–88.4; 19 66.7; 29.9–92.5; 6
E. coli ESBL (%; 95%CI; n) 23.1; 8.9–43.6; 6 11.1; 0.3–48.3; 1
K. pneumoniae ESBL/FQ (%; 95%CI; n) 3.8; 0.0–19.6; 1 22.2; 2.8–60.0; 2
MDRGN with resistance to carbapenems 0 0
  1. Abbreviations: HIV human immunodeficiency virus; HP males tested positive for infection with HIV; HN males tested negative for infection with HIV; MDRGN multidrug-resistant gram-negative organism. E. coli ESBL: resistant due to ESBL expression; E. coli/K. pneumoniae ESBL/FQ: ESBL and resistance to fluoroquinolones